Patient Navigation in Cancer Survivorship at a Safety Net Institution

This study seeks to enroll patients receiving a Survivorship Care Plan following curative
therapy for cancer. Participants will be randomly assigned to receive usual care or to be
followed by a Patient Navigator as part of their Survivorship Care Plan.

Study participation for all participants will be for up to 9 months, with study visits
approximately every 3 months, based on standard clinical follow-up. All participants will be
administered quality of life surveys by a Clinical Research Associate at study entry,
mid-study (approximately 3-6 months) and at study completion.

The following factors will be compared between arms:

- Missed/kept appointments

- Use of urgent/emergent care

- Quality of Life in relation to survivorship care

- Participants lost to care

Inclusion Criteria:

- Stage I, II, III or IVa Cancer diagnosis (may include Solitary plasmacytoma, Diffuse
Large B-Cell Lymphoma (DLBCL), ductal carcinoma in situ (DCIS) of the breast)

- Completed treatment with curative intent within the past 12 months. (May be on
maintenance therapy.)

Exclusion Criteria:

- Distant Metastatic disease

- Non-curable disease

- Recurrence of disease prior to enrollment

- Require ongoing navigation from the treatment navigator

- Enrolled/active in another randomized study (Project SUPPORT)